These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. How academic labs can approach the drug discovery process as a way to synergize with big pharma. Loregian A; Palù G Trends Microbiol; 2013 Jun; 21(6):261-4. PubMed ID: 23731493 [TBL] [Abstract][Full Text] [Related]
4. Partners in discovery. Fuyuno I Nature; 2018 Mar; 555(7697):S60. PubMed ID: 29565400 [No Abstract] [Full Text] [Related]
5. Global strategic partnerships in regenerative medicine. French A; Suh JY; Suh CY; Rubin L; Barker R; Bure K; Reeve B; Brindley DA Trends Biotechnol; 2014 Sep; 32(9):436-40. PubMed ID: 25150363 [TBL] [Abstract][Full Text] [Related]
6. Universities shun Europe's drug initiative. Gilbert N Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770 [No Abstract] [Full Text] [Related]
8. Academia and industry: Companies on campus. Watson-Capps JJ; Cech TR Nature; 2014 Oct; 514(7522):297-8. PubMed ID: 25318508 [No Abstract] [Full Text] [Related]
9. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia]. Iida K; Yano T; Ikemori M; Ishida T; Nishimura N Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438 [TBL] [Abstract][Full Text] [Related]
10. Rescuing the Lost in Translation. Gehr S; Garner CC Cell; 2016 May; 165(4):765-70. PubMed ID: 27153487 [TBL] [Abstract][Full Text] [Related]
11. Public-private partnerships in translational medicine: concepts and practical examples. Luijten PR; van Dongen GA; Moonen CT; Storm G; Crommelin DJ J Control Release; 2012 Jul; 161(2):416-21. PubMed ID: 22465390 [TBL] [Abstract][Full Text] [Related]
12. The way back. Schiermeier Q Nature; 2010 Jul; 466(7304):402-3. PubMed ID: 20734461 [No Abstract] [Full Text] [Related]
13. Expanding industry partnerships through an accelerated business engagement program. Seeley RJ; Witbeck G; Mulholland MW Surgery; 2019 Aug; 166(2):143-146. PubMed ID: 29803564 [No Abstract] [Full Text] [Related]
14. Open innovation networks between academia and industry: an imperative for breakthrough therapies. Melese T; Lin SM; Chang JL; Cohen NH Nat Med; 2009 May; 15(5):502-7. PubMed ID: 19424212 [No Abstract] [Full Text] [Related]
15. Academia-pharma partnerships for novel drug discovery: essential or nice to have? Palmer M; Chaguturu R Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189 [No Abstract] [Full Text] [Related]
16. Leveraging public private partnerships to innovate under challenging budget times. Portilla LM; Rohrbaugh ML Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971 [TBL] [Abstract][Full Text] [Related]
17. The role of public-private partnerships in addressing the biomedical innovation challenge. Said M; Zerhouni E Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362 [TBL] [Abstract][Full Text] [Related]
18. Welcome to the future of integrated neuroscience. Mohammadi D Lancet Neurol; 2014 Oct; 13(10):971-2. PubMed ID: 25231520 [No Abstract] [Full Text] [Related]
19. Leveraging crowdsourcing to facilitate the discovery of new medicines. Norman TC; Bountra C; Edwards AM; Yamamoto KR; Friend SH Sci Transl Med; 2011 Jun; 3(88):88mr1. PubMed ID: 21697527 [TBL] [Abstract][Full Text] [Related]
20. Drug development partnerships look set to grow. Watts G Lancet; 2016 Jul; 388(10039):16-8. PubMed ID: 27397780 [No Abstract] [Full Text] [Related] [Next] [New Search]